THC Stock Cash Flow Statements

Tenet Healthcare Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Tenet Healthcare Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-03-31	2005-09-30	2005-06-30	2005-03-31	2004-09-30

net income	522,000,000	622,000,000	572,000,000	681,000,000	477,000,000	2,334,000,000	456,000,000	266,000,000	293,000,000	296,000,000	274,000,000	268,000,000	179,000,000	280,000,000	419,000,000	578,000,000	257,000,000	222,000,000	111,931,000	-106,000,000	169,000,000	159,000,000	264,449,000	-152,000,000	112,000,000	65,000,000	-66,735,000	65,000,000	108,000,000	191,000,000	488,815,000	-289,000,000	23,000,000	80,000,000	39,000,000	34,000,000	2,000,000	28,000,000	-28,000,000	76,000,000			-7,000,000	-16,000,000	-14,000,000	36,000,000	-43,000,000	-83,000,000	54,000,000	32,000,000	-20,000,000	67,000,000	-66,000,000	15,000,000	63,000,000	82,000,000	82,000,000	940,000,000	35,000,000	95,000,000	29,000,000	-1,000,000	-14,000,000	183,000,000	-33,000,000	104,000,000	-15,000,000	-31,000,000	-75,000,000	-59,000,000	-30,000,000	75,000,000	70,000,000	-408,000,000	-21,000,000	-3,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	208,000,000	206,000,000	193,000,000	209,000,000	208,000,000	208,000,000	216,000,000	224,000,000	213,000,000	217,000,000	213,000,000	209,000,000	216,000,000	203,000,000	201,000,000	209,000,000	221,000,000	224,000,000	-583,714,000	215,000,000	206,000,000	203,000,000	-587,038,000	205,000,000	214,000,000	208,000,000	-570,171,000	204,000,000	194,000,000	204,000,000	-634,265,000	219,000,000	218,000,000	205,000,000	215,000,000	212,000,000	208,000,000	185,000,000	197,000,000	207,000,000	240,000,000	207,000,000	209,000,000	193,000,000	191,000,000	119,000,000	121,000,000	114,000,000	116,000,000	110,000,000	100,000,000	104,000,000	105,000,000	103,000,000	104,000,000	101,000,000	101,000,000	101,000,000	97,000,000	95,000,000	95,000,000	97,000,000	97,000,000	97,000,000	96,000,000	90,000,000	92,000,000	95,000,000	93,000,000	91,000,000	89,000,000	89,000,000	90,000,000	105,000,000	92,000,000	96,000,000	98,000,000
deferred income tax expense	7,000,000	4,000,000	-74,000,000	64,000,000	-55,000,000	-38,000,000	-23,000,000	38,000,000	29,000,000	8,000,000	1,000,000	76,000,000	69,000,000	63,000,000	67,000,000	135,000,000	24,000,000	24,000,000						15,000,000	23,000,000	19,000,000		2,000,000	38,000,000	70,000,000		-64,000,000	9,000,000	-5,000,000	6,000,000	31,000,000				12,000,000									34,000,000	21,000,000	-1,000,000	38,000,000	-21,000,000	11,000,000	56,000,000	35,000,000	32,000,000	-996,000,000	7,000,000	5,000,000	3,000,000	6,000,000	8,000,000	3,000,000	-24,000,000	-5,000,000	-5,000,000	21,000,000
stock-based compensation expense	20,000,000	21,000,000	15,000,000	16,000,000	19,000,000	17,000,000	18,000,000	15,000,000	19,000,000	14,000,000	9,000,000	13,000,000	18,000,000	16,000,000	13,000,000	13,000,000	16,000,000	14,000,000		11,000,000	14,000,000	13,000,000		11,000,000	12,000,000	11,000,000		14,000,000	11,000,000	9,000,000		15,000,000	17,000,000	16,000,000	19,000,000	16,000,000	19,000,000	17,000,000	18,000,000	15,000,000	10,000,000	15,000,000	14,000,000	12,000,000	10,000,000	7,000,000	8,000,000	11,000,000	8,000,000	7,000,000	9,000,000	8,000,000	7,000,000	5,000,000	5,000,000	7,000,000	4,000,000	5,000,000	6,000,000	7,000,000	5,000,000	5,000,000	6,000,000	7,000,000	6,000,000	7,000,000	10,000,000	10,000,000
impairment and restructuring charges, and acquisition-related costs	24,000,000	19,000,000	27,000,000	19,000,000	29,000,000	27,000,000	53,000,000	47,000,000	16,000,000	21,000,000	129,000,000	24,000,000	57,000,000	16,000,000	30,000,000	15,000,000	20,000,000	20,000,000		57,000,000	54,000,000	55,000,000		46,000,000	36,000,000	19,000,000		46,000,000	30,000,000	47,000,000		329,000,000	121,000,000	31,000,000	22,000,000	28,000,000	52,000,000	44,000,000	193,000,000	29,000,000	63,000,000	37,000,000	32,000,000	21,000,000	58,000,000	20,000,000	11,000,000	14,000,000
litigation and investigation costs	28,000,000	17,000,000	17,000,000	9,000,000	5,000,000	4,000,000	19,000,000	14,000,000	10,000,000	4,000,000	20,000,000	12,000,000	18,000,000	20,000,000	52,000,000	29,000,000	22,000,000	13,000,000		9,000,000	2,000,000	2,000,000		84,000,000	18,000,000	13,000,000		9,000,000	13,000,000	6,000,000		6,000,000	2,000,000	4,000,000	114,000,000	173,000,000	224,000,000	50,000,000	14,000,000	3,000,000	6,000,000	4,000,000	12,000,000	3,000,000	28,000,000	1,000,000	2,000,000	0	2,000,000	0	1,000,000	2,000,000	31,000,000	5,000,000	8,000,000	11,000,000		2,000,000	2,000,000	2,000,000			9,000,000	1,000,000		-5,000,000	3,000,000	47,000,000	12,000,000
net incomees (gains) on sales, consolidation and deconsolidation of facilities										-13,000,000										-1,000,000	-1,000,000	-2,000,000		1,000,000	1,000,000	1,000,000
income from early extinguishment of debt			0	0	0	8,000,000	0	0			0	0	66,000,000	43,000,000	0	20,000,000	31,000,000	23,000,000		312,000,000				180,000,000	0	47,000,000		0	1,000,000	1,000,000		138,000,000									0	24,000,000	0	0	0	0	171,000,000	177,000,000																										0	0	15,000,000	0
equity in earnings of unconsolidated affiliates, net of distributions received	-13,000,000	5,000,000	-20,000,000	-6,000,000	-6,000,000	3,000,000	-18,000,000	-2,000,000	-4,000,000	11,000,000	-12,000,000	-4,000,000	-3,000,000	21,000,000	-20,000,000	0	-18,000,000	28,000,000		28,000,000	-28,000,000	-11,000,000	6,150,000	-4,000,000	-5,000,000	3,000,000	-8,844,000	-1,000,000	1,000,000	9,000,000	4,645,000	-8,000,000	-15,000,000	-8,000,000	-2,000,000	12,000,000
amortization of debt discount and debt issuance costs	6,000,000	6,000,000	5,000,000	7,000,000	6,000,000	8,000,000	7,000,000	7,000,000	9,000,000	9,000,000	10,000,000	8,000,000	7,000,000	8,000,000	8,000,000	8,000,000	8,000,000	9,000,000		10,000,000	10,000,000	10,000,000		4,000,000	10,000,000	11,000,000		11,000,000	11,000,000	11,000,000		11,000,000	8,000,000	12,000,000	11,000,000	10,000,000	9,000,000	11,000,000	14,000,000	7,000,000	7,000,000	7,000,000	7,000,000	7,000,000	7,000,000	3,000,000	4,000,000	5,000,000	6,000,000	5,000,000	6,000,000	5,000,000	7,000,000	8,000,000	7,000,000	8,000,000
net gains from the sale of investments and long-lived assets			-2,000,000	-1,000,000			-4,000,000	-10,000,000	-1,000,000	-14,000,000	-2,000,000
other items	-3,000,000	2,000,000	-1,000,000	0	2,000,000	-5,000,000	-3,000,000	2,000,000	-1,000,000	-2,000,000	1,000,000	71,000,000	5,000,000	-64,000,000	-10,000,000	-1,000,000	-15,000,000	-7,000,000		-1,000,000	-5,000,000	2,000,000		-4,000,000	-3,000,000	-7,000,000		-21,000,000	0	-1,000,000		6,000,000	13,000,000	1,000,000	0	2,000,000	85,000,000	-1,000,000			-24,000,000	-18,000,000	2,000,000	0	0	1,000,000	0	2,000,000	9,000,000	9,000,000	-3,000,000	5,000,000	18,000,000	-7,000,000	8,000,000	-13,000,000	-27,000,000	7,000,000	10,000,000	6,000,000	-4,000,000	-8,000,000	-3,000,000	9,000,000	9,000,000	5,000,000	-6,000,000	3,000,000	3,000,000	0			8,000,000	1,000,000	3,000,000	3,000,000	4,000,000
changes in cash from operating assets and liabilities:
accounts receivable	109,000,000	-69,000,000	62,000,000	106,000,000	340,000,000	-263,000,000	-60,000,000	24,000,000	-28,000,000	35,000,000	-101,000,000	35,000,000	77,000,000	-151,000,000	5,000,000	-101,000,000	-48,000,000	-53,000,000		-37,000,000	303,000,000	14,000,000		-36,000,000	20,000,000	-158,000,000		-23,000,000	53,000,000	-66,000,000		-373,000,000	-448,000,000	-431,000,000	-272,000,000	-453,000,000	-508,000,000	-345,000,000	-295,000,000	-484,000,000	-587,000,000													-155,000,000	-192,000,000	-278,000,000	-207,000,000	-160,000,000	-135,000,000	-242,000,000	-148,000,000	-179,000,000	-90,000,000	-229,000,000	-170,000,000	-121,000,000	-117,000,000	-243,000,000
inventories and other current assets	117,000,000	-108,000,000	-96,000,000	-6,000,000	34,000,000	-18,000,000	-90,000,000	-209,000,000	110,000,000	50,000,000	-153,000,000	-84,000,000	-8,000,000	181,000,000	59,000,000	-167,000,000	-74,000,000	130,000,000		-14,000,000	21,000,000	23,000,000		-34,000,000	51,000,000	-115,000,000		-71,000,000	185,000,000	-41,000,000		-63,000,000	12,000,000	-65,000,000	-12,000,000	-18,000,000	-68,000,000	-98,000,000	110,000,000	-74,000,000	-326,000,000	-66,000,000												22,000,000	55,000,000	-113,000,000	-19,000,000	10,000,000	-11,000,000	3,000,000	3,000,000	-9,000,000	0	-16,000,000	-6,000,000	-11,000,000	14,000,000	1,000,000			-3,000,000	10,000,000	11,000,000			16,000,000
income taxes	-122,000,000	132,000,000	-805,000,000	108,000,000	-70,000,000	783,000,000	56,000,000	-15,000,000	-107,000,000	76,000,000	33,000,000	27,000,000	-115,000,000	29,000,000	1,000,000	42,000,000	6,000,000	19,000,000		-5,000,000	12,000,000	2,000,000		-2,000,000	-11,000,000	9,000,000		4,000,000				-7,000,000			-45,000,000	28,000,000			1,000,000	8,000,000								3,000,000				3,000,000		-18,000,000	-12,000,000	-14,000,000	-37,000,000	-10,000,000	33,000,000	17,000,000	-91,000,000	-8,000,000	17,000,000	4,000,000	11,000,000	-3,000,000	-12,000,000	-17,000,000	9,000,000	14,000,000				-4,000,000
accounts payable, accrued expenses and other current liabilities	0	24,000,000	-153,000,000	247,000,000														-87,000,000		337,000,000	1,353,000,000	-144,000,000		180,000,000	-108,000,000	-109,000,000		177,000,000	-188,000,000	-183,000,000		204,000,000	-16,000,000	71,000,000	8,000,000	-114,000,000	29,000,000	306,000,000	-67,000,000	-200,000,000	385,000,000			29,000,000										20,000,000	-74,000,000	-44,000,000	62,000,000	18,000,000	-18,000,000	-146,000,000	49,000,000	82,000,000	-2,000,000	-117,000,000	15,000,000	45,000,000	72,000,000	-161,000,000
other long-term liabilities	40,000,000	-8,000,000	-27,000,000	-5,000,000	-1,000,000	24,000,000	4,000,000	-2,000,000	21,000,000	-9,000,000	13,000,000	13,000,000	-20,000,000	-21,000,000	20,000,000	14,000,000	-12,000,000	6,000,000		115,000,000	141,000,000	-51,000,000		-19,000,000	-33,000,000	37,000,000		-34,000,000	-49,000,000	1,000,000		-41,000,000	-8,000,000	14,000,000	10,000,000	24,000,000	7,000,000	-9,000,000	12,000,000	28,000,000	6,000,000	-9,000,000	34,000,000	13,000,000			-22,000,000	27,000,000	-17,000,000	-6,000,000	10,000,000	16,000,000		-19,000,000	-4,000,000	12,000,000	-35,000,000	-5,000,000	9,000,000	-27,000,000	-7,000,000	5,000,000	1,000,000	-12,000,000	-10,000,000	-1,000,000			16,000,000	8,000,000	6,000,000	9,000,000	14,000,000	17,000,000	-16,000,000	31,000,000	9,000,000
payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	-45,000,000	-36,000,000	-34,000,000	-55,000,000	-39,000,000	-25,000,000	-49,000,000	-27,000,000	-54,000,000	-24,000,000	-57,000,000	-59,000,000	-42,000,000	-56,000,000	-37,000,000	-31,000,000	-34,000,000	-51,000,000		-138,000,000	-46,000,000	-68,000,000		-56,000,000	-48,000,000	-32,000,000		-50,000,000	-30,000,000	-33,000,000		-26,000,000	-559,000,000	-33,000,000	-30,000,000	-69,000,000	-43,000,000	-71,000,000	-53,000,000	-33,000,000	-53,000,000
net cash from operating activities	936,000,000	815,000,000	-331,000,000	1,045,000,000	747,000,000	586,000,000	824,000,000	503,000,000	598,000,000	449,000,000	421,000,000	315,000,000	119,000,000	228,000,000	357,000,000	432,000,000	245,000,000	534,000,000	-2,503,798,000	593,000,000	2,239,000,000	129,000,000	-386,035,000	419,000,000	284,000,000	10,000,000	-468,532,000	338,000,000	348,000,000	113,000,000	-406,934,000	308,000,000	-293,000,000	269,000,000	435,000,000	147,000,000	191,000,000	482,000,000	410,000,000	-57,000,000	219,000,000	221,000,000			255,000,000	206,000,000			256,000,000	136,000,000			173,000,000	148,000,000	178,000,000	-2,000,000		128,000,000	191,000,000	-22,000,000	141,000,000	120,000,000	170,000,000	-6,000,000	67,000,000	151,000,000	123,000,000	-133,000,000	112,000,000	83,000,000				-15,000,000	184,000,000	516,000,000	123,000,000
capex	-193,000,000	1,325,000,000	-330,000,000	-216,000,000	-145,000,000	-240,000,000	-208,000,000	-176,000,000	-132,000,000	-235,000,000	-290,000,000	-165,000,000	-152,000,000	-155,000,000	-304,000,000	-112,000,000	-225,000,000	1,715,000,000	0	-86,000,000	-106,000,000	-182,000,000	0	-134,000,000	-136,000,000	1,415,000,000	0	-136,000,000	-125,000,000	-143,000,000	0	-144,000,000	-261,000,000	-201,000,000	-205,000,000	-208,000,000	-276,000,000	-207,000,000	-175,000,000	-184,000,000	-199,000,000	0			0	0			0	0			0	-100,000,000	-82,000,000	-116,000,000		-119,000,000	-70,000,000	-78,000,000	-181,000,000	-78,000,000	-53,000,000	-86,000,000	0	-105,000,000	-83,000,000	-160,000,000	0	0				0	0	0	0
free cash flows	743,000,000	2,140,000,000	-661,000,000	829,000,000	602,000,000	346,000,000	616,000,000	327,000,000	466,000,000	214,000,000	131,000,000	150,000,000	-33,000,000	73,000,000	53,000,000	320,000,000	20,000,000	2,249,000,000	-2,503,798,000	507,000,000	2,133,000,000	-53,000,000	-386,035,000	285,000,000	148,000,000	1,425,000,000	-468,532,000	202,000,000	223,000,000	-30,000,000	-406,934,000	164,000,000	-554,000,000	68,000,000	230,000,000	-61,000,000	-85,000,000	275,000,000	235,000,000	-241,000,000	20,000,000	221,000,000			255,000,000	206,000,000			256,000,000	136,000,000			173,000,000	48,000,000	96,000,000	-118,000,000		9,000,000	121,000,000	-100,000,000	-40,000,000	42,000,000	117,000,000	-92,000,000	67,000,000	46,000,000	40,000,000	-293,000,000	112,000,000	83,000,000				-15,000,000	184,000,000	516,000,000	123,000,000
cash flows from investing activities:
purchases of property and equipment	-193,000,000	-173,000,000	-330,000,000	-216,000,000	-145,000,000	-240,000,000	-208,000,000	-176,000,000	-132,000,000	-235,000,000	-290,000,000	-165,000,000	-152,000,000	-155,000,000	-304,000,000	-111,000,000	-122,000,000	-121,000,000
purchases of businesses or joint venture interests, net of cash acquired	-120,000,000	-27,000,000	-47,000,000	-14,000,000	-61,000,000	-449,000,000	-114,000,000	-14,000,000	-48,000,000	-48,000,000	-10,000,000	-158,000,000	-26,000,000	-40,000,000	-1,156,000,000	0	-39,000,000	-25,000,000		-5,000,000	-1,000,000	-55,000,000		-10,000,000	-11,000,000	-2,000,000		-8,000,000	-73,000,000	-16,000,000		-15,000,000	-21,000,000	-2,000,000	-65,000,000	-29,000,000	-220,000,000	-84,000,000	-625,000,000	-11,000,000	-243,000,000
proceeds from sales of facilities and other assets	3,000,000	11,000,000	16,000,000	917,000,000	18,000,000	4,030,000,000	33,000,000	22,000,000	3,000,000	13,000,000	1,000,000	0	61,000,000	148,000,000		1,111,000,000	111,000,000	13,000,000										17,000,000	56,000,000	425,000,000		752,000,000	0	0	0	573,000,000	521,000,000																																								105,000,000
proceeds from sales of marketable securities and long-term investments	23,000,000	14,000,000	38,000,000	8,000,000	10,000,000	7,000,000
purchases of marketable securities and long-term investments	-21,000,000	-17,000,000	-48,000,000	-20,000,000	-16,000,000	-10,000,000
net cash from investing activities	-314,000,000	-187,000,000	-372,000,000	667,000,000	-194,000,000	3,328,000,000	-333,000,000	-169,000,000	-181,000,000	-286,000,000	-306,000,000	-302,000,000	-140,000,000	-60,000,000	-1,516,000,000	997,000,000	-50,000,000	-145,000,000	196,808,000	-117,000,000	-85,000,000	-204,000,000	392,582,000	-123,000,000	-164,000,000	-139,000,000	-182,230,000	-105,000,000	-148,000,000	373,000,000	-256,946,000	535,000,000	-280,000,000	-204,000,000	-266,000,000	320,000,000	-45,000,000	-287,000,000	-798,000,000	-187,000,000	-408,000,000													-93,000,000	-102,000,000	-129,000,000		-145,000,000	-58,000,000	-68,000,000	-180,000,000	-95,000,000	-24,000,000	174,000,000	-71,000,000	8,000,000	-50,000,000	-161,000,000
cash flows from financing activities:
repayments of borrowings	-30,000,000	-32,000,000	-31,000,000	-33,000,000	-38,000,000	-2,141,000,000	-64,000,000	-41,000,000	-1,392,000,000	-45,000,000		-42,000,000	-1,865,000,000	-879,000,000																																								-2,000,000	-1,000,000	-1,000,000	0	-874,000,000	-5,000,000	-7,000,000	-6,000,000	-384,000,000	-900,000,000	-1,000,000	0	0	0	-1,000,000
proceeds from borrowings	14,000,000	1,000,000	7,000,000	8,000,000	6,000,000	2,000,000	2,000,000	6,000,000	1,350,000,000	12,000,000		7,000,000	2,011,000,000	2,000,000																																							900,000,000	0	0	0	0	600,000,000	0	1,000,000	0	0
repurchases of common stock	-747,000,000	-348,000,000	0	-124,000,000	-270,000,000	-278,000,000	-110,000,000	0	-40,000,000	-50,000,000																																	0	0										-124,000,000
distributions paid to noncontrolling interests	-185,000,000	-189,000,000	-185,000,000	-173,000,000	-161,000,000	-162,000,000	-169,000,000	-155,000,000	-136,000,000	-134,000,000	-128,000,000	-122,000,000	-175,000,000	-135,000,000	-107,000,000	-104,000,000	-93,000,000	-119,000,000		-84,000,000	-24,000,000	-76,000,000		-79,000,000	-70,000,000	-74,000,000		-77,000,000	-76,000,000	-64,000,000		-55,000,000	-67,000,000	-56,000,000	-51,000,000	-44,000,000	-45,000,000	-42,000,000	-12,000,000	-11,000,000	-15,000,000													-4,000,000	-2,000,000	-2,000,000	-2,000,000	-3,000,000	-2,000,000	-1,000,000	-2,000,000	-2,000,000
proceeds from the sale of noncontrolling interests	7,000,000	11,000,000	10,000,000	3,000,000	5,000,000	5,000,000	6,000,000	7,000,000	5,000,000	25,000,000		7,000,000
purchases of noncontrolling interests	-38,000,000	-41,000,000	-73,000,000	-39,000,000	-36,000,000	-52,000,000	-40,000,000	-48,000,000	-38,000,000	-41,000,000	-39,000,000	-32,000,000	-15,000,000	-14,000,000	-8,000,000	-14,000,000	-3,000,000	-2,000,000	30,133,000				-4,792,000	-2,000,000	-3,000,000	-3,000,000	634,785,000	-1,000,000	-633,000,000	-9,000,000	716,553,000	-717,000,000
advances from managed care payers			0	0
repayments of advances from managed care payers	-1,000,000	-11,000,000	-150,000,000
net cash from financing activities	-996,000,000	-648,000,000	-372,000,000	-498,000,000	-154,000,000	-2,661,000,000	-317,000,000	-214,000,000	-249,000,000	-255,000,000	-465,000,000	-156,000,000	-33,000,000	-1,127,000,000	1,231,000,000	-1,331,000,000	-142,000,000	-694,000,000	-701,819,000	-690,000,000	747,000,000	426,000,000	81,976,000	-231,000,000	-123,000,000	-30,000,000	758,698,000	-136,000,000	-771,000,000	-123,000,000	956,235,000	-889,000,000	640,000,000	-72,000,000	-241,000,000	-95,000,000	-240,000,000	-44,000,000	502,000,000	236,000,000	182,000,000	-89,000,000	284,000,000	338,000,000							-153,000,000	169,000,000		-134,000,000	-79,000,000	-7,000,000	-19,000,000	-296,000,000	-11,000,000	-11,000,000	-2,000,000	-52,000,000	-40,000,000	-23,000,000	-1,000,000	1,000,000					0	1,000,000	1,000,000	-2,000,000	1,000,000	349,000,000	1,000,000
net increase in cash and cash equivalents	-374,000,000	-20,000,000	-1,075,000,000	1,214,000,000	399,000,000	1,253,000,000	174,000,000	120,000,000							72,000,000	98,000,000	53,000,000	-305,000,000		-214,000,000	2,901,000,000	351,000,000				-159,000,000				363,000,000		-46,000,000	67,000,000	-7,000,000	-72,000,000	372,000,000	-94,000,000	151,000,000			-7,000,000	-206,000,000	265,000,000	28,000,000													7,000,000	-313,000,000	122,000,000	-101,000,000	-41,000,000	-27,000,000	106,000,000	145,000,000										-114,000,000	97,000,000	843,000,000	130,000,000
cash and cash equivalents at beginning of period	0	3,019,000,000	0	0	0	1,228,000,000	0	0	0	858,000,000	0	0	0	2,364,000,000	0	0	0	2,446,000,000		0	0	262,000,000		0	0	411,000,000		0	0	611,000,000		0	0	0	0	356,000,000	0	0	0	193,000,000	0	0	0	113,000,000	0	0	0	364,000,000	0	0	0	113,000,000	0	0	0	405,000,000	0	0	0	690,000,000	0	0	0	507,000,000	0	0	0	572,000,000	0	0	0	784,000,000	1,373,000,000	0	0	654,000,000	0
cash and cash equivalents at end of period	-374,000,000	2,999,000,000	-1,075,000,000	1,214,000,000	399,000,000	2,481,000,000	174,000,000	120,000,000	168,000,000	766,000,000	-350,000,000	-143,000,000	-54,000,000	1,405,000,000	72,000,000	98,000,000	53,000,000	2,141,000,000		-214,000,000	2,901,000,000	613,000,000		65,000,000	-3,000,000	252,000,000		97,000,000	-571,000,000	974,000,000		-46,000,000	67,000,000	-7,000,000	-72,000,000	728,000,000	-94,000,000	151,000,000	114,000,000	185,000,000	-7,000,000	-206,000,000	265,000,000	141,000,000	31,000,000	-8,000,000	-5,000,000	95,000,000	281,000,000	1,000,000	-22,000,000	104,000,000	-72,000,000	-79,000,000	-3,000,000	267,000,000	7,000,000	-313,000,000	122,000,000	589,000,000	-41,000,000	-27,000,000	106,000,000	652,000,000	-5,000,000	160,000,000	74,000,000	278,000,000	-83,000,000	-20,000,000	91,000,000	584,000,000	975,000,000	-114,000,000	97,000,000	1,497,000,000	130,000,000
supplemental disclosures:
interest paid, net of capitalized interest	-300,000,000	-99,000,000	-296,000,000	-96,000,000	-297,000,000	-162,000,000	-293,000,000	-144,000,000	-268,000,000	-177,000,000	-247,000,000	-185,000,000	-250,000,000	-166,000,000	-273,000,000	-178,000,000	-296,000,000	-190,000,000		-292,000,000	-293,000,000	-172,000,000		-221,000,000	-326,000,000	-158,000,000		-151,000,000	-332,000,000	-169,000,000		-149,000,000	-336,000,000	-129,000,000	-335,000,000	-132,000,000	-340,000,000	-134,000,000	-268,000,000	-117,000,000	-239,000,000	-127,000,000	-255,000,000	-105,000,000	-131,000,000	-69,000,000	-101,000,000	-125,000,000	-88,000,000	-107,000,000	-79,000,000	-102,000,000	-92,000,000	-73,000,000	-85,000,000	-97,000,000	-89,000,000	-112,000,000	-89,000,000	-112,000,000	-99,000,000	-100,000,000	-91,000,000	-149,000,000	-70,000,000	-126,000,000	-70,000,000	-125,000,000	-81,000,000	-123,000,000	-67,000,000	-124,000,000	-123,000,000	-131,000,000	-67,000,000	-94,000,000
income tax payments	-235,000,000	-7,000,000	-963,000,000	-68,000,000	-235,000,000	-5,000,000	-31,000,000	-54,000,000			-13,000,000	-8,000,000	-132,000,000	-8,000,000	-38,000,000	-20,000,000	-32,000,000	-2,000,000		-5,000,000				-5,000,000				-3,000,000				-10,000,000	0	-4,000,000											-1,000,000	3,000,000						-2,000,000
hospital operations:
goodwill at beginning of period, net of accumulated impairment losses				0
goodwill acquired during the year, net of purchase price allocation adjustments
goodwill related to assets held for sale and disposed				-183,000,000
goodwill at end of period, net of accumulated impairment losses				-172,000,000
ambulatory care:
goodwill at beginning of period
goodwill related to assets held for sale and disposed or deconsolidated facilities
goodwill at end of period
total goodwill, net of accumulated impairment losses
net gains on sales, consolidation and deconsolidation of facilities		-22,000,000	-10,000,000	-348,000,000	-58,000,000	-2,500,000,000	-11,000,000	1,000,000								-412,000,000												7,000,000
at march 31, 2025:
other intangible assets with finite useful lives:
capitalized software costs		1,498,000,000														-1,000,000	-103,000,000	1,836,000,000						22,000,000	8,000,000	1,607,000,000
contracts		241,000,000														-1,000,000	-1,000,000	872,000,000						1,000,000	4,000,000	870,000,000
other		91,000,000														1,000,000	-10,000,000	111,000,000						-1,000,000	-1,000,000	106,000,000
other intangible assets with finite lives		1,830,000,000
other intangible assets with indefinite useful lives:
trade names		105,000,000														0	0	102,000,000						0	0	102,000,000
other intangible assets with indefinite lives		882,000,000
total other intangible assets		2,712,000,000
debt issuance costs							0	-1,000,000			0	0	-21,000,000	-3,000,000	-16,000,000	0				-26,000,000	-21,000,000	-1,000,000		-45,000,000	0	-18,000,000						-33,000,000					-4,000,000	-4,000,000
current assets
noncurrent assets
current liabilities
noncurrent liabilities
noncontrolling interests
net operating revenues
net income attributable to the investees
purchase price allocation adjustments
accounts payable, accrued expenses, contract liabilities and other current liabilities						19,000,000	253,000,000	130,000,000	62,000,000	-230,000,000	44,000,000	-178,000,000	-404,000,000	-360,000,000	-435,000,000	83,000,000
pre-tax loss (income) from discontinued operations																					0	1,000,000								-1,000,000					2,000,000	5,000,000
net cash from operating activities from discontinued operations, excluding income taxes											0													1,000,000	-3,000,000	-2,000,000		-1,000,000	-2,000,000	-1,000,000		-1,000,000					-3,000,000				-7,000,000													-22,000,000	-6,000,000	-13,000,000	2,000,000	-7,000,000	3,000,000	2,000,000	9,000,000	3,000,000	-28,000,000	56,000,000		34,000,000				-6,000,000	-8,000,000	17,000,000		-24,000,000	32,000,000	45,000,000	-42,000,000
purchases of marketable securities and equity investments							-50,000,000	-17,000,000	-19,000,000	-18,000,000	-24,000,000	-27,000,000	-22,000,000	-19,000,000	-85,000,000	-4,000,000	-8,000,000	-11,000,000		-31,000,000	-6,000,000	-4,000,000
medicare advances and grants received by unconsolidated affiliates, net of recoupment															-59,000,000	-14,000,000
grant funds received from covid-19 relief programs:
included in cash flows from operating activities:
hospital operations								-4,000,000	4,000,000	3,000,000		-46,000,000	93,000,000	4,000,000
ambulatory care													1,000,000	1,000,000
included in cash flows from financing activities:
cash‑managed affiliates
pre-tax income from discontinued operations														-1,000,000										-1,000,000	-2,000,000	-10,000,000															0			8,000,000						-3,000,000				2,000,000				3,000,000																22,000,000	18,000,000	23,000,000	148,000,000
proceeds from sales of marketable securities, long-term investments and other assets								14,000,000	17,000,000	9,000,000	15,000,000	52,000,000	3,000,000	6,000,000	13,000,000	0	12,000,000	6,000,000		9,000,000	25,000,000	10,000,000		43,000,000	5,000,000	4,000,000		22,000,000	9,000,000	134,000,000		4,000,000	26,000,000	12,000,000	12,000,000	12,000,000	42,000,000	9,000,000	3,000,000	6,000,000	29,000,000	-1,000,000	0	3,000,000	9,000,000	3,000,000	0	3,000,000	8,000,000	4,000,000	2,000,000	3,000,000	28,000,000	21,000,000	5,000,000	5,000,000	53,000,000	15,000,000	4,000,000	12,000,000	12,000,000	6,000,000	31,000,000	18,000,000	32,000,000	178,000,000	4,000,000	10,000,000		205,000,000
grant income recognized from covid-19 relief programs:
included in grant income:
net decrease in cash and cash equivalents										-92,000,000		-143,000,000	-54,000,000	-959,000,000										65,000,000				97,000,000																												-138,000,000									-5,000,000	160,000,000	74,000,000	-294,000,000
repayments of borrowings under credit facility																				0	-500,000,000	-240,000,000		-785,000,000	-600,000,000	-495,000,000		-145,000,000				-750,000,000	-700,000,000	0	-200,000,000	-995,000,000	-935,000,000	-565,000,000	-625,000,000	-690,000,000	-465,000,000
proceeds from borrowings under credit facility																				0	0	740,000,000		870,000,000	600,000,000	685,000,000		145,000,000				750,000,000	700,000,000	0	200,000,000	995,000,000	825,000,000	575,000,000	375,000,000	820,000,000	685,000,000	665,000,000	465,000,000	430,000,000					140,000,000	460,000,000
repayments of other borrowings															-38,000,000	-1,171,000,000	-1,471,000,000	-541,000,000		-3,015,000,000	-181,000,000	-48,000,000		-4,416,000,000	-48,000,000	-1,620,000,000		-77,000,000	-70,000,000	-91,000,000		-3,070,000,000	-42,000,000	-36,000,000	-38,000,000	-38,000,000	-38,000,000	-19,000,000	-1,960,000,000	-32,000,000	-28,000,000
proceeds from other borrowings															1,459,000,000	4,000,000	1,405,000,000	4,000,000		2,503,000,000	1,305,000,000	7,000,000		4,202,000,000	9,000,000	1,507,000,000		1,000,000	7,000,000	7,000,000		2,951,000,000	756,000,000			1,000,000	-50,000,000	21,000,000	2,786,000,000	401,000,000	0	500,000,000	508,000,000	600,000,000	4,600,000,000	0	1,057,000,000	850,000,000	800,000,000	0
proceeds from sale of noncontrolling interests														4,000,000	11,000,000	2,000,000	6,000,000	6,000,000		2,000,000	3,000,000	2,000,000											3,000,000	4,000,000
net incomees on sales, consolidation and deconsolidation of facilities														1,000,000
grant payments received from covid-19 relief programs:
unconsolidated affiliates for which we provide cash management services
proceeds from sales of facilities and other assets — continuing operations																				1,000,000	1,000,000	11,000,000		4,000,000	-1,000,000	41,000,000
proceeds from sales of facilities and other assets — discontinued operations																								0	0	17,000,000															2,000,000				5,000,000	10,000,000			0	35,000,000			0	0				1,000,000			0	0	-30,000,000	251,000,000		77,000,000	60,000,000	23,000,000	8,000,000
proceeds from shares issued under stock-based compensation plans, net of taxes paid relatedto net share settlement
at september 30, 2021:
total																-1,000,000	-114,000,000	2,921,000,000						22,000,000	11,000,000	2,685,000,000
proceeds from exercise of stock options and employee stock purchase plan																	2,000,000	7,000,000		8,000,000	3,000,000	2,000,000		1,000,000	2,000,000	1,000,000		1,000,000	5,000,000	9,000,000
at june 30, 2021:
other long-term assets																		-8,000,000				-2,000,000		5,000,000	-2,000,000	-2,000,000		2,000,000	-4,000,000	7,000,000		-4,000,000				-10,000,000				2,000,000					-3,000,000	5,000,000	-23,000,000	29,000,000
medicare advances and grants received by unconsolidated affiliates																		19,000,000
at march 31, 2021:
cash flows from operating activities:
benefit from doubtful accounts																															-1,086,497,000	355,000,000	354,000,000	367,000,000	352,000,000	376,000,000	391,000,000	371,000,000	352,000,000	363,000,000	356,000,000	249,000,000	320,000,000	380,000,000	348,000,000	210,000,000	207,000,000	207,000,000	200,000,000	206,000,000	186,000,000	193,000,000	184,000,000	193,000,000	171,000,000	182,000,000	191,000,000	187,000,000	173,000,000	189,000,000	181,000,000	193,000,000	167,000,000	156,000,000	166,000,000	164,000,000	153,000,000	149,000,000	134,000,000	141,000,000	151,000,000	141,000,000	138,000,000	206,000,000	153,000,000	158,000,000	228,000,000
amortization of debt issue costs
equity in earnings (losses) of unconsolidated affiliates, net of distributions received
loss/(gain) on sale of assets
noncash lease expense
changes in operating assets and liabilities, net of effects from purchases of new businesses:
decrease/(increase) in patient receivables
decrease/(increase) in supplies, prepaid, and other assets
increase in contract liabilities
(decrease)/increase in accounts payable, accrued expenses, and other liabilities
purchases of new businesses and equity interests, net of cash received
sale of property and equipment
decrease/(increase) in deposits and notes receivables
other investing activities
(increase)/decrease in funds due from united surgical partners, inc.
proceeds from debt obligations
payments on debt obligations
distributions to noncontrolling interest owners
sales of noncontrolling interests
contribution from members
distributions to members
increase/(decrease) in cash and restricted cash
cash and restricted cash, beginning of period
cash and restricted cash, end of period
supplemental information:
cash paid for interest
cash paid for income taxes
noncash transactions:
assets acquired under finance lease obligations
(decrease)/increase in accounts payable due to property and equipment received but not paid
tyler acquisition
right of use assets acquired under operating leases
reconciliation of cash and restricted cash:
cash at beginning of period
restricted cash at beginning of period
cash and restricted cash at beginning of period
cash at end of period
restricted cash at end of period
cash and restricted cash at end of period
deferred income tax (benefit) expense																				-197,000,000	30,000,000	-79,000,000
purchases of property and equipment — continuing operations																				-86,000,000	-106,000,000	-182,000,000		-156,000,000	-144,000,000	-192,000,000		-136,000,000	-125,000,000	-143,000,000		-144,000,000	-261,000,000	-201,000,000	-205,000,000	-208,000,000	-276,000,000	-207,000,000	-175,000,000	-184,000,000	-199,000,000													-100,000,000	-82,000,000	-116,000,000		-106,000,000	-70,000,000	-78,000,000	-181,000,000	-78,000,000	-53,000,000	-85,000,000		-99,000,000	-74,000,000	-159,000,000
at december 31, 2019:
deferred income taxes																				0	-90,000,000	259,000,000
professional and general liability reserves																				0	-37,000,000	622,000,000
accumulated deficit																				0	-48,000,000	-2,419,000,000
income tax (payments) refunds																						-3,000,000																											-4,000,000	2,000,000						-24,000,000									-1,000,000	0	-4,000,000	1,000,000	-6,000,000	0
at march 31, 2020:
increase in patient receivables
(increase)/decrease in supplies, prepaid, and other assets
increase in accounts payable, accrued expenses, and other liabilities
purchases of new businesses and equity interests, net of cash received of 0, 925, and 0 for 2019, 2018 and 2017, respectively
change in deposits and notes receivables
change in funds due from united surgical partners, inc.
(decrease)/increase in cash and restricted cash
assets acquired under capital leases
centennial acquisition
managed care
medicare
medicaid
indemnity, self-pay, and other
purchases of equity investments																								-5,000,000	-8,000,000	-1,000,000		-6,000,000	-7,000,000	-30,000,000		-62,000,000	-2,000,000	-2,000,000	-17,000,000	-18,000,000	-116,000,000
proceeds from sales of noncontrolling interests																								6,000,000	5,000,000	4,000,000		7,000,000	2,000,000	5,000,000		15,000,000
at september 30, 2019:
at june 30, 2019:
income tax refunds																										9,000,000																												-11,000,000				0	17,000,000	17,000,000
at march 31, 2019:
loss on fixed asset impairment
(gain) loss on sale of assets
increase in supplies, prepaids, and other assets
(decrease) /increase in accounts payable, accrued expenses, and other liabilities
purchases of new businesses and equity interests, net of cash received of 925, 0 and 394 for 2018, 2017 and 2016, respectively
increase in cash
cash, beginning of period
cash, end of period
increase in accounts payable due to property and equipment received but not paid
sunnyvale acquisition
restricted cash borrowed
restricted cash from purchases of equipment
restricted cash from payments on debt obligations
commercial and managed care providers
government-related programs
self-pay patients
at september 30, 2018:
gains on sales, consolidation and deconsolidation of facilities																														-110,000,000		-104,000,000	0	-3,000,000	-1,000,000	-147,000,000
income tax refunds (payments)																														1,000,000										1,000,000				-1,000,000				3,000,000														-7,000,000
gain on sale of assets
purchases of new businesses and equity interests, net of cash received of 0 and 135 for 2017 and 2016, respectively
proceeds from employee stock plan purchases																																2,000,000
other assets
pre-tax (income) income from discontinued operations																																																3,000,000								15,000,000				-6,000,000
purchase of noncontrolling interests																																	-6,000,000	-3,000,000			0	0
proceeds from exercise of stock options																																	0	1,000,000			0	6,000,000	2,000,000	7,000,000	3,000,000	12,000,000	5,000,000	6,000,000	0	1,000,000	6,000,000	15,000,000																										2,000,000	1,000,000	8,000,000
contributions from noncontrolling interests																																					1,000,000	0	1,000,000	2,000,000	3,000,000	2,000,000	0	13,000,000	1,000,000	0													0	1,000,000
undistributed earnings from affiliates
deferred income tax benefit																																						17,000,000
deferred debt issuance costs																																									-1,000,000																-12,000,000	-15,000,000			1,000,000	-1,000,000	-24,000,000	-22,000,000
purchase of noncontrolling interest																																								-254,000,000
purchases of property and equipment — discontinued operations																																													0	0												-13,000,000			0	0	0	-1,000,000		-6,000,000	-9,000,000	-1,000,000
repurchases of preferred stock																																													0
cash dividends on preferred stock																																													0	0	0	0						-6,000,000	-6,000,000	-6,000,000	-6,000,000	-6,000,000	-6,000,000	-6,000,000
pre-tax gain from discontinued operations
proceeds from interest rate swap agreement																																																									0				21,000,000
purchases of businesses or joint venture interests																																																						-14,000,000	-24,000,000	-18,000,000
proceeds from borrowing under credit facility																																														558,000,000	433,000,000	220,000,000				658,000,000
impairment of long-lived assets and goodwill, and restructuring charges																																																	7,000,000	6,000,000	3,000,000	3,000,000	9,000,000	8,000,000	2,000,000	8,000,000		3,000,000				7,000,000	1,000,000	5,000,000		1,000,000	2,000,000	1,000,000				3,000,000				9,000,000
fair market value adjustments related to interest rate swap and libor cap agreements																																																			0	0	0	-17,000,000	-2,000,000	19,000,000	0	0			0	-4,000,000
payments against reserves for restructuring charges and litigation costs and settlements																																																																	-21,000,000	-23,000,000
construction of new and replacement hospitals																																																					0	0	0	0	0	-1,000,000	-7,000,000	-5,000,000	-11,000,000	-13,000,000	-18,000,000	-16,000,000	-10,000,000	-9,000,000	-27,000,000	-29,000,000
release of escrow funds
net gain on sales of investments																																																									0	0			0	0
gain from early extinguishment of debt																																																															21,000,000	-134,000,000
purchases of marketable securities																																																									0	0			0	-11,000,000			-9,000,000	-9,000,000	-1,000,000	-7,000,000
distributions received from investments in reserve yield plus fund																																																										0					0	8,000,000
proceeds from hospital authority bonds																																																									0	0			0	0			0				0
proceeds from issuance of mandatory convertible preferred stock																																																									0				0
payments against reserves for restructuring charges and litigation costs																																																						-6,000,000	-14,000,000	-7,000,000		-25,000,000	-27,000,000	-24,000,000		-109,000,000	-28,000,000	-28,000,000				-27,000,000
purchase of property and equipment — discontinued operations
impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries																																																																					36,000,000	11,000,000
litigation and investigation costs, net of insurance recoveries																																																													18,000,000
(gain) income from early extinguishment of debt																																																									2,000,000
amortization of debt discount and issue costs
pre-tax (gain) income from discontinued operations
net cash from operating activities cash flows from investing activities:
purchases of property and equipment—continuing operations
purchases of property and equipment—discontinued operations
purchases of business or joint venture interest
proceeds from sales of facilities and other assets—discontinued operations
distributions received from (reclassification of) investments in reserve yield plus fund																																																													1,000,000
proceeds from cash surrender value or basis reduction of insurance policies																																																																	7,000,000
net cash from investing activities cash flows from financing activities:
purchase of businesses or joint venture interest
purchase of business or joint venture interest																																																																	0
fair market value adjustments related to libor cap agreement																																																												2,000,000
net gain from early extinguishment of debt																																																													0
pretax income from discontinued operations																																																													-9,000,000	3,000,000	20,000,000	9,000,000		10,000,000	-16,000,000	19,000,000
insurance recoveries for property damage
purchase of business
dividends paid to noncontrolling interests																																																																-2,000,000
net gains on sales of investments
pretax (income) income from discontinued operations																																																																					-8,000,000	38,000,000	-1,000,000	31,000,000
cumulative effect of change in accounting principle
insurance recoveries for business interruption and other costs
net cash from operating activities from discontinued operations, excluding income taxes and insurance recoveries for business interruption and other costs
reclassification of investments in reserve yield plus fund out of cash equivalents																																																																	34,000,000
release of restricted cash related to letter of credit facility
cumulative effect of changes in accounting principle
proceeds from sale of marketable securities, long-term investments and other assets
sale of new senior notes																																																																										0	0	773,000,000	0
repurchases of senior notes
stock-based compensation charges																																																																						10,000,000	10,000,000	11,000,000	11,000,000	12,000,000	13,000,000	13,000,000	25,000,000
increases (decreases) in cash from changes in operating assets and liabilities:
construction of new hospitals.
proceeds from cash surrender value of insurance policies
proceeds from sales of facilities — discontinued operations																																																																							9,000,000	38,000,000
costs of litigation and investigations
proceeds from sales of long-term investments and other assets																																																																								174,000,000
income tax payments made																																																																								-2,000,000
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from sales of facilities:
purchase of property and buyout of discontinued operation joint venture interest
proceeds from sales of facilities, investments and other assets																																																																									26,000,000
payments of borrowings
income tax refunds received (payments made)																																																																									-3,000,000	-6,000,000	-2,000,000	537,000,000
impairment of long-lived assets and restructuring charges																																																																									1,000,000
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of new businesses and sales of facilities:
income taxes payable																																																																									4,000,000			541,000,000
purchases of property and equipment:
continuing operations
gulf coast operations
discontinued operations
insurance recoveries																																																																									10,000,000
impairment and restructuring charges																																																																										205,000,000
construction of new hospitals
deposits on purchases of property and equipment
net cash released from escrow accounts to fund construction costs
proceeds from sales of facilities, long-term investments and other assets																																																																										36,000,000	46,000,000	71,000,000
investment in hospital authority bonds
other items, including expenditures related to prior-year purchases of new businesses																																																																												3,000,000
impairment of long-lived assets, goodwill and investment securities, and restructuring charges
increase in cash from changes in operating assets and liabilities, net of effects from purchases and sales of businesses:
cash released from escrow accounts to fund construction costs
payments of other borrowings
interest paid																																																																													46,000,000
income taxes paid, net of refunds received																																																																													0
cash released from escrow account to fund construction costs
adjustments to reconcile net income
income tax benefit related to stock option exercises
discontinued operations impairment charge
other items, including, in 2003, settlements of litigation and investigations
repurchases of senior, senior subordinated and exchangeable subordinated notes
impairment, restructuring and other unusual charges
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of businesses:
net expenditures for discontinued operations and other unusual charges
purchases of businesses, net of cash acquired
purchases of treasury stock

We provide you with 20 years of cash flow statements for Tenet Healthcare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Tenet Healthcare stock. Explore the full financial landscape of Tenet Healthcare stock with our expertly curated income statements.

The information provided in this report about Tenet Healthcare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.